MERGE LABS

gene therapy products for enabling and developing brain computer interface (BCI) systems

Downloadable and recorded software for providing direct interfaces between the brain and computer systems; downloadable and recorded software for directly controlling and communicating with computers and electronic devices via neural activity; downloadable and recorded software for controlling brain-computer interface (BCI) devices; downloadable and recorded software for interpreting and decoding neural activity; downloadable and recorded software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems

Brain-computer interface (BCI) devices; implants for directly controlling and communicating with computers and electronic devices via neural activity; devices for opening the blood-brain barrier; computers and electronic devices for directly modulating brain states; devices for detecting brain function

Providing online non-downloadable software featuring software that provides a direct interface between the brain and computer systems; software as a service (SAAS) services featuring software that allows users to directly control and communicate with computers using neural activity; providing online non-downloadable software for controlling brain-computer interface (BCI) devices; providing online non-downloadable software and recorded software for interpreting and decoding neural activity; providing online non-downloadable software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; research and development in the field of brain-computer interfaces (BCI), direct communication between brain activity and computers, neurostimulation, and therapeutics; providing information in the field of brain-computer interfaces (BCI); gene therapy research; research and development in the field of artificial intelligence (AI) and machine learning (ML) for use in brain-computer interface (BCI) devices, neurostimulation, and therapeutics